Pharmacologic studies of low-dose and high-dose continuous infusion cytosine arabinoside.
Kufe
D W
DW
Spriggs
D R
DR
Griffin
J D
JD
D000328:Adult; D000368:Aged; D001085:Arabinofuranosylcytosine Triphosphate / Q000378:metabolism; D001086:Arabinofuranosyluracil / Q000378:metabolism; D003561:Cytarabine / Q000008:administration & dosage* / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology; D004261:DNA Replication / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012093:Replicon / Q000187:drug effects; D013921:Thrombocytopenia / Q000139:chemically induced
D003561:Cytarabine; D001085:Arabinofuranosylcytosine Triphosphate; D001086:Arabinofuranosyluracil